FDA Inspection 883466 — Midwest Transplant Network
The FDA completed an inspection of Midwest Transplant Network on Jun 2, 2014 in Topeka, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 2, 2014
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Topeka, KS (United States)